LGALS3 and ovarian cancer: Besides, the addition of different concentrations of TD-139, a potent small-molecule inhibitor of galectin-3, did not improve γδ T-cell cytotoxicity against ovarian cancer cells after 24 hours (Figure 4A) or at earlier time points (Supplementary Figure 2).